Skip to main content
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest
  • facebook
  • twitter
  • linkedin
  • youtube
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest

A Single-center, Interventional Diagnostic Study With Minimal Risks and Constraints, Aimed at Longitudinally Evaluating Serum Antibody Levels in Patients With COVID-19 According to the Severity of Their Symptoms.

  • Read more about A Single-center, Interventional Diagnostic Study With Minimal Risks and Constraints, Aimed at Longitudinally Evaluating Serum Antibody Levels in Patients With COVID-19 According to the Severity of Their Symptoms.

A Study of CX2101A Enteric-Coated Tablets in Healthy Chinese Adult Subjects

  • Read more about A Study of CX2101A Enteric-Coated Tablets in Healthy Chinese Adult Subjects

Open, Non-comparative Study to Evaluate the Effectiveness and Safety of the Medical Device KOS® M in Lip Augmentation

  • Read more about Open, Non-comparative Study to Evaluate the Effectiveness and Safety of the Medical Device KOS® M in Lip Augmentation

Improving Sports and Recreation Services in Mashhad for Elderly and Intergenerational Interaction (ESPIRE-M)

  • Read more about Improving Sports and Recreation Services in Mashhad for Elderly and Intergenerational Interaction (ESPIRE-M)

Colostrum From MERS-CoV Seropositive Camels for SARS-CoV-2 Infection - a Placebo-controlled Randomized Trial.

  • Read more about Colostrum From MERS-CoV Seropositive Camels for SARS-CoV-2 Infection - a Placebo-controlled Randomized Trial.

Expanded Access to Vedolizumab for Children and Teenagers With Ulcerative Colitis or Crohn's Disease in the USA

  • Read more about Expanded Access to Vedolizumab for Children and Teenagers With Ulcerative Colitis or Crohn's Disease in the USA

Bionic Sight, Inc.

By jpalfreyman on Mon, 03/03/2025 - 16:28
  • Read more about Bionic Sight, Inc.

OnCusp Therapeutics, Inc.

By jpalfreyman on Mon, 03/03/2025 - 16:24
  • Read more about OnCusp Therapeutics, Inc.

Luxa Biotechnology LLC

By jpalfreyman on Mon, 03/03/2025 - 16:21
  • Read more about Luxa Biotechnology LLC

Pharming Group NV

By jpalfreyman on Mon, 03/03/2025 - 16:18
  • Read more about Pharming Group NV

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 23
  • Page 24
  • Page 25
  • Page 26
  • Current page 27
  • Page 28
  • Page 29
  • Page 30
  • Page 31
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Subscribe for updates from the Reagan-Udall Foundation for the FDA

Subscribe
(202) 849 - 2075
1333 New Hampshire Ave, NW
Suite 420
Washington, DC 20036
navigator@reaganudall.org
  • facebook
  • twitter
  • linkedin
  • youtube

© Reagan-Udall Foundation for the FDA
© Reagan-Udall Foundation for the FDA